Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2006 (Vol. 26, No. 19)

Antibody Engineering Methods Advance

Addressing a Host of Immune Response Challenges

  • Antibody engineering is moving into its fourth decade, a stage of maturity that emphasizes both the success and the challenges of the discipline. One problem that antibody-engineering companies have long struggled with is the host immune response to biologic therapeutics. Researchers will meet at IBC’s Antibody Engineering Conference ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.